Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

16.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 47.50
  • 52 Week Low: 7.75
  • Currency: UK Pounds
  • Shares Issued: 245.63m
  • Volume: 172,759
  • Market Cap: £39.30m
  • RiskGrade: 504

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
98.86% above the market average98.86% above the market average98.86% above the market average98.86% above the market average98.86% above the market average
93.94% above the sector average93.94% above the sector average93.94% above the sector average93.94% above the sector average93.94% above the sector average
Price Book Ratio
100% below the market average100% below the market average100% below the market average100% below the market average100% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
62.45% below the market average62.45% below the market average62.45% below the market average62.45% below the market average62.45% below the market average
61.4% below the sector average61.4% below the sector average61.4% below the sector average61.4% below the sector average61.4% below the sector average
Price Chg 3m
70.11% above the market average70.11% above the market average70.11% above the market average70.11% above the market average70.11% above the market average
54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
19.46% above the market average19.46% above the market average19.46% above the market average19.46% above the market average19.46% above the market average
3.57% below the sector average3.57% below the sector average3.57% below the sector average3.57% below the sector average3.57% below the sector average
Momentum 20
28.23% below the market average28.23% below the market average28.23% below the market average28.23% below the market average28.23% below the market average
39.29% below the sector average39.29% below the sector average39.29% below the sector average39.29% below the sector average39.29% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
99.34% below the market average99.34% below the market average99.34% below the market average99.34% below the market average99.34% below the market average
94.74% below the sector average94.74% below the sector average94.74% below the sector average94.74% below the sector average94.74% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
73.59% below the market average73.59% below the market average73.59% below the market average73.59% below the market average73.59% below the market average
28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
96.33% below the market average96.33% below the market average96.33% below the market average96.33% below the market average96.33% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Operating Profit Loss
85% below the market average85% below the market average85% below the market average85% below the market average85% below the market average
39.29% below the sector average39.29% below the sector average39.29% below the sector average39.29% below the sector average39.29% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
53.96% below the market average53.96% below the market average53.96% below the market average53.96% below the market average53.96% below the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average
Cash
39.78% below the market average39.78% below the market average39.78% below the market average39.78% below the market average39.78% below the market average
47.17% below the sector average47.17% below the sector average47.17% below the sector average47.17% below the sector average47.17% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
80.36% below the market average80.36% below the market average80.36% below the market average80.36% below the market average80.36% below the market average
87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average
Buys 1y
33.1% below the market average33.1% below the market average33.1% below the market average33.1% below the market average33.1% below the market average
23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
65.16% above the market average65.16% above the market average65.16% above the market average65.16% above the market average65.16% above the market average
6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average6.25% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 16.00p
Change Today -1.00p
% Change -5.88 %
52 Week High 47.50
52 Week Low 7.75
Volume 172,759
Shares Issued 245.63m
Market Cap £39.30m
RiskGrade 504

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.04% below the market average49.04% below the market average49.04% below the market average49.04% below the market average49.04% below the market average
41.82% below the sector average41.82% below the sector average41.82% below the sector average41.82% below the sector average41.82% below the sector average
Price Trend
16.99% below the market average16.99% below the market average16.99% below the market average16.99% below the market average16.99% below the market average
40.35% below the sector average40.35% below the sector average40.35% below the sector average40.35% below the sector average40.35% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 09-Jul-2020

Time Volume / Share Price
15:47 1,500 @ 16.09p
15:08 5,000 @ 15.70p
14:51 10,386 @ 16.00p
14:35 10,000 @ 15.72p
14:08 4,850 @ 15.98p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page